INTRODUCTION
Immunoadsorbents have been used to isolate and to purify antibody (see references 1, 2) and to remove specifically reactive cells from heterogeneous populations of lymphocytes (3, 4) . We have recently described the use of a solid-phase immunoadsorbent for the removal of antibody from the sera of immunized animals (5, 6) . Portions of plasma were exposed to batches of immunoadsorbent, and the adsorbed plasma was returned together with red cells to the animals. By sequential repetition of this procedure, 50-80% of the intravascular antibody could be removed specifically from actively immunized animals. This maneuver is too complicated for general use, however, and also has the disadvantage that trace amounts of immunoadsorbent are released into the animals.
The present study describes the characterization of a solid-phase immunoadsorbent in agar gel and its use Quantities of proteins in solutions used were estimated spectrophotometrically from the optical densities at 280 and 260 mau, respectively (7).
Antibodies. IgG fractions were purified from sera of rabbits hyperimmunized against BSA, mouse, or chicken IgG, and also from normal rabbits. IgG was salted out with ammonium sulfate, and the dialyzed precipitate was chromatographed on DEAE-cellulose or DEAE-Sephadex (A-25).
Iodination of proteins. Proteins were iodinated with 'I or 'I (New England Nuclear Corp., Boston, Mass.) by the method described by McConahey and Dixon (8) . The radioiodine was NaI which was free of carrier and thiosulfate.
Preparation of solid immunoadsorbent. Bromoacetyl cellulose (BAC) was obtained from Miles-Yeda, Ltd. (Rehovoth, Israel). BAC-protein immunoadsorbents were prepared by the method of Robbins, Haimovich, and Sela (1). The last step of the procedure, i.e. exposure of the adsorbent to 8 M urea was eliminated, since it proved possible to remove all noncovalently bound protein from the cellulose derivative by extensive washing with saline.
Preparation of solid immunoadsorbent agar gel. BAC-BSA or BAC-rabbit IgG was suspended in an equal volume of saline and diluted (1:1 or 1: 3) with thorough mixing in melted noble agar (3% in saline) at 50-550C. The mixture was then poured onto the surface of a glass funnel to form a film or into a mold to form a column. The funnel had been previously coated by a thin film of 1% agar, which was allowed to dry completely. The mold to form the column consisted of a glass tube, 25 cm in length and 0.9 cm in internal diameter into which a glass rod of lesser diameter (0.5 cm) was centered by the use of rubber stoppers. In this manner, an annulus of space was created into which the liquid immunoadsorbent-agar mixture was poured. After hardening of the agar, the glass rod was removed, creating a column lined with immunoadsorbent through which solutions or an animal's blood could be passed. Adams (9) . The proportion of antibody to BSA in the rabbit anti-BSA-t'I IgG was estimated by the following method. 0.1-ml portions of serum were incubated with 1 ml of the BAC-BSA suspension (containing 37 mg of BSA) at 37°C for 10 min followed by the removal of BAC-BSA by centrifugation (10,000 g, 10 min). This absorbtion was performed three times using 1 ml of fresh BAC-BSA suspension. The third portion of adsorbent remained virtually free of radioactivity. The total amounts of radioactivity removed (corrected for nonspecific adsorption) was used as a measure of antibody specific to BSA.
Determination of radioactivity. Radioactive fractions were counted in a Nuclear-Chicago well counter. All counts are net and statistically significant. Spillover of 'I into 'WI counts was corrected for when necessary.
RESULTS
Specificity of binding of BSA-immunoadsorbent in agar. To investigate this question, the following experiment was performed: 1 ml of the immunoadsorbent agar suspension was added to plastic test tubes and allowed to solidify. To each tube was added 1 ml of equimolar concentrations (100 /lg) of one of the following purified MI-labeled IgG's: rabbit anti-BSA, rabbit anti-chicken, rabbit anti-mouse, or normal rabbit IgG. After incubation for 15 min at room temperature, the tubes were decanted. The immunoadsorbent agar gel s1.27 x 10 cpm.
6.7 X 10 -1.3 X 107 cpm. As can be seen in Table II , 79-83% of circulating anti-BSA was removed in the four animals tested. In contrast, the levels of circulating antibody to bacteriophage were only decreased by 8-14%. The amount of antibody removed ranged from 17 to 61 l'g of protein as calculated from the specific radioactivity of the anti-BSA and the total radioactivity removed. It is not known whether all the antigenic sites on the immunoadsorbent were saturated with antibody.
Release of antigen from BSA-immunoadsorbent in agar. In order to determine whether BSA bound to the BAC-agar was released and entered the circulation during the procedure, the BSA in the immunoadsorbent used in the previous experiments had been labeled with 'I. Three of the above experimental rabbits were sacrificed at the end of the extracorporeal circulation. The entire thyroid, spleen, kidneys, 10% of liver weight, several grams of muscle tissue, 5 ml of blood, and in one case both lungs were collected, and the level of radioactivity due to 'I was determined.
As can be seen in Table III , no significant 'I counts could be found in the organs tested though 1 X 108 cpm 'I-labeled BSA was present on the immunoadsorbent used. The present studies indicate that antibody can be removed specifically and rapidly from the circulation of immunized animals. The technique used was to incorporate an immunoadsorbent (e.g. BAC-BSA) into agar, thus forming a solid gel which was used to line the inside of glass columns and funnels. After extracorporeal circulation through such columns or over such funnels, approximately 80% of intravascular antibody was removed in 30-60 min. In contrast, the levels of a control antibody remained virtually unchanged throughout the procedure. No detectable antigen was released from the immunoadsorbent into the animals used in these experiments. The actual amounts injected and removed were small. However, there exists a proportionality between surface area of the immunoadsorbent in gel and its capacity to remove specific materials. We therefore suggest that with appropriate development in engineering, the capacity for specific removal could be easily and strikingly increased.
The possibility of manipulating humoral antibody levels by this simple and effective method has several experimental and therapeutic implications. Experimentally, it should be possible to probe further into the physiological mechanisms regulating the synthesis of antibody. Therapeutically, this method could be applied to remove autoantibodies involved in the pathogenesis of disease or to remove the "blocking" antibody believed to play a role in the propagation of tumors (14) (15) (16) (17) ).
An unresolved problem in therapeutic application is that the removal of antibody in actively immunized animals is followed by a rapid rise of serum antibody back to the original levels (6, 18) . A possible solution applicable to autoimmune diseases would be the subsequent administration of specific antibody which cannot bind C' such as Fab' or F(ab')2 but which can suppress antibody synthesis (19, 20) .
We have also shown that antibody conjugated to the solid immunoadsorbent in gel can be used to remove antigen from the circulation. Hence, using the specificity of antibody, it should be possible to remove any circulating molecule, provided an antibody can be prepared to it. Using the appropriate immunoadsorbent, components of complement, hormones, endotoxin, digitalis, or toxic chemicals could be removed. Moreover, different immunoadsorbents could be used in sequence. For example, simultaneous use of antibody and antigen-containing immunoadsorbents would allow removal of immune reactants from patients with immune complex disease without the necessity of establishing whether the patient is in the phase of antigen or antibody excess.
